| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/03/2002 | EP1193271A2 Compositions and methods for protein structural determinations |
| 04/03/2002 | EP1192281A2 Use of ras inhibitors for inhibiting muscle atrophy |
| 04/03/2002 | EP1192280A1 Synthetic ligation reassembly in directed evolution |
| 04/03/2002 | EP1192278A1 48 human secreted proteins |
| 04/03/2002 | EP1192271A1 Antisense modulation of interleukin-5 signal transduction |
| 04/03/2002 | EP1192266A2 Complement-resistant non-mammalian dna viruses and uses thereof |
| 04/03/2002 | EP1192261A1 22025, a novel human cyclic nucleotide phosphodiesterase |
| 04/03/2002 | EP1192260A2 Arabidopsis thaliana cdc7 and cdc27 homologs |
| 04/03/2002 | EP1192259A1 Tankyrase2 materials and methods |
| 04/03/2002 | EP1192258A2 Human poly(adp-ribose) polymerase 2 materials and methods |
| 04/03/2002 | EP1192257A2 Human regulators of intracellular phosphorylation |
| 04/03/2002 | EP1192256A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 04/03/2002 | EP1192254A1 Helical polypeptide zalpha29 |
| 04/03/2002 | EP1192252A2 Secreted protein zacrp4 |
| 04/03/2002 | EP1192251A1 Human sel-10 polypeptides and polynucleotides that encode them |
| 04/03/2002 | EP1192250A2 Human rna metabolism proteins (rmep) |
| 04/03/2002 | EP1192249A1 47 human secreted proteins |
| 04/03/2002 | EP1192247A1 Sphingosine kinase enzyme |
| 04/03/2002 | EP1192244A1 Genetically modified plant cells and plants with an increased activity of an amylosucrase protein and a branching enzyme |
| 04/03/2002 | EP1192243A1 Method for enhancing hematopoiesis |
| 04/03/2002 | EP1192183A2 Diagnostic test for thrombotic or thromboembolic disease |
| 04/03/2002 | EP1192179A2 Compound derived from an offset orf of the ice gene |
| 04/03/2002 | EP1192176A1 49 human secreted proteins |
| 04/03/2002 | EP1192174A2 Antagonists of bmp and tgf beta signalling pathways |
| 04/03/2002 | EP1192171A1 48 human secreted proteins |
| 04/03/2002 | EP1191940A1 Tumor necrosis factor receptor 5 |
| 04/03/2002 | EP1191937A1 Adhesive n,o-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins |
| 04/03/2002 | EP1191839A1 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
| 04/03/2002 | EP0856051B1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof |
| 04/03/2002 | EP0736002B1 Compound capable of introducing at least one molecule into a cell |
| 04/03/2002 | EP0726941B1 Methods for (ex vivo) therapy using peptide-loaded antigen presenting cells for the activation of ctl |
| 04/03/2002 | EP0722489B1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
| 04/03/2002 | EP0605428B1 Hormone-secreting pancreatic cells maintained in long-term culture |
| 04/03/2002 | CN1343221A Polypeptide variants with altered effector function |
| 04/03/2002 | CN1081924C Pharmaceutical composition comprising plant worms and muirapuama |
| 04/02/2002 | US6365807 Method of creating a transformed rice plant |
| 04/02/2002 | US6365802 Methods for increasing stearate content in soybean oil |
| 04/02/2002 | US6365799 Hygromycin-resistant transgenic plants |
| 04/02/2002 | US6365798 Method for enhancement of naturally occurring cytoplasmic male sterility and for restoration of male fertility and uses thereof in hybrid crop production |
| 04/02/2002 | US6365757 Culturing tissues of taxus wallichiania; isolation by partitioning the culture product residue, obtained by polar solvent extraction; desolventizing between water and chlorinated solvents; evaporation; chromotography; adsorption; |
| 04/02/2002 | US6365728 Regulatory element for expressing genes in plants |
| 04/02/2002 | US6365716 Binds to epitope of polypeptide having defined amino acid sequence; antitumor agents |
| 04/02/2002 | US6365715 Human cardiac/brain tolloid-like protein |
| 04/02/2002 | US6365714 Amino acid sequence of a polypeptide; antiinflammatory agents; antiproliferative agents; antiapoptotic agents |
| 04/02/2002 | US6365712 Isolated soluble cd antigen; diagnosis and treatment of related disorders |
| 04/02/2002 | US6365616 Transplant rejection |
| 04/02/2002 | US6365414 Vitro system for determining formation of Aβ amyloid |
| 04/02/2002 | US6365407 Culture medium composition useful for induction and proliferation of Taxus calli |
| 04/02/2002 | US6365405 Compositions of chondrocytes, preparation and utilization |
| 04/02/2002 | US6365404 Reducing viral replication of human immunodeficiency virus by administering t-lymphocytes which have been rendered incapable of viral replication and have increased cell surface membrane density of viral receptors |
| 04/02/2002 | US6365403 High-efficiency AAV helper functions |
| 04/02/2002 | US6365394 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus |
| 04/02/2002 | US6365391 Isolated human serine protease, nucleic acid molecules encoding human serine protease, and uses thereof |
| 04/02/2002 | US6365389 Human protein kinase H2LAU20 |
| 04/02/2002 | US6365386 Polynucleotide which codes for enzyme that converts beta-carotene to astaxanthin |
| 04/02/2002 | US6365385 Culturing with antioxidant, anticytokine, antiendotoxin and antibiotic; microencapsulating in biocompatible structure having core and semipermeable outer membrane; then incubating in physiological salt to increase capsule durability |
| 04/02/2002 | US6365371 Amino acid sequence; diagnosis, prevention and treatment of cancer, reproductive disorders, immune disorders, and developmental disorders; anticarcinogenic agents |
| 04/02/2002 | US6365370 Dna which codes for 5-hydroxytryptamine 3-c protein of defined amino acid sequence; antiinflammatory agents; treatment of huntington's disease, alzheimer's disease and others |
| 04/02/2002 | US6365365 Method of determining whether an agent modulates glycosyl sulfotransferase-3 |
| 04/02/2002 | US6365360 Methods of identifying modulators of human IP prostaglandin receptor |
| 04/02/2002 | US6365359 Identifying prp pharmacore by determining functional residues of protein involved in complex interactions, developing three dimensional structures, comparing them with other compounds and identifying compounds consistent with binding to protein |
| 04/02/2002 | US6365358 Polypeptide of defined amino acid sequence; diagnosis, prevention and treatment of cancer, developmental, autoimmune and nervous system disorders; anticarcinogenic agents; antiinflammatory agents |
| 04/02/2002 | US6365155 Monoclonal antibody, antibody fragment, mixture or derivative thereof, which binds to ancrod and inhibits its activity |
| 04/02/2002 | US6365154 Tie2 agonist antibodies |
| 04/02/2002 | US6365153 Culturing selected cells, plating the cultured cells onto an overlying and an underlying membranes and moving the overlying membrane across the underlaying membrane to stretch and split into two populations connected by elongated cells |
| 04/02/2002 | CA2359465A1 The application of bi-directional promoters for modification of gene expression |
| 04/02/2002 | CA2222914C Novel cd40l mutein |
| 04/02/2002 | CA2086835C Tissue plasminogen activator variants with decreased clearance |
| 04/02/2002 | CA1341353C Viral vector and recombinant dna coding for a glycoprotein of the aids (virus) causative agent, cellular culture infected by this vector, manufacturing method for the glycoprotein, and resulting glycoprotein, vaccine and antibody |
| 03/29/2002 | CA2340303A1 Rna-binding protein |
| 03/28/2002 | WO2002024930A2 Artificial ubiquitous chromatin opening elements (ucoe) |
| 03/28/2002 | WO2002024926A1 Talaromyces xylanases |
| 03/28/2002 | WO2002024924A2 Protein phosphatases |
| 03/28/2002 | WO2002024920A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/28/2002 | WO2002024914A1 Modification of plant cell wall component and method of regulating development differentiation |
| 03/28/2002 | WO2002024912A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof |
| 03/28/2002 | WO2002024910A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 03/28/2002 | WO2002024909A2 Receptor nucleic acids and polypeptides |
| 03/28/2002 | WO2002024907A2 G-protein coupled receptor hfrbn63 |
| 03/28/2002 | WO2002024897A2 Conditionally replicating viral vectors and their use |
| 03/28/2002 | WO2002024892A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof |
| 03/28/2002 | WO2002024891A2 B7-like molecules and uses thereof |
| 03/28/2002 | WO2002024879A2 Glutaryl cephalosporin amidase from pseudomonas diminuta bs-203 |
| 03/28/2002 | WO2002024875A1 Culture liquor for normal human matured liver cells |
| 03/28/2002 | WO2002024874A2 Methods for preparing interferon producing dentitric cells |
| 03/28/2002 | WO2002024873A1 Stem cell therapy |
| 03/28/2002 | WO2002024872A2 Manipulation of spermatozoa |
| 03/28/2002 | WO2002024871A1 Method for in vitro propagation of the agent responsible for transmissible spongiform encephalopathies |
| 03/28/2002 | WO2002024749A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 03/28/2002 | WO2002024748A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/28/2002 | WO2002024738A1 β-CATENIN NUCLEAR LOCALIZED PROTEIN |
| 03/28/2002 | WO2002024733A2 Human polynucleotides and polypeptides encoded thereby |
| 03/28/2002 | WO2002024730A2 Transduction of dendritic cells using adenoviral vectors |
| 03/28/2002 | WO2002024727A2 New inhibitors of iapp fibril formation and uses thereof |
| 03/28/2002 | WO2002024726A2 Olfactory and pheromones g-protein coupled receptors |
| 03/28/2002 | WO2002024224A2 Use of replication-deficient poxvirus vector to boost cd4+ t cell immune response to antigen |
| 03/28/2002 | WO2002024219A1 Growth factor complex |
| 03/28/2002 | WO2002011743A3 Treatment of prostate cancer |
| 03/28/2002 | WO2001098333A3 Modification of hepatitis b core antigen |
| 03/28/2002 | WO2001094952A3 Methods and compositions for modulating oxidized ldl transport |